A vaccine damage scheme is being worked on by the Department of Health, it has been confirmed. “The development of such a ...

Zymeworks is awaiting key regulatory decisions for zanidatamab, with potential EU and China approvals following. Read more ...

With an approval based on two pivotal Phase III studies, Dupixent is now the first-ever biologic indicated for treating COPD.

Pandemic exposed EU states to worrying pharma supply shortages, leading to widespread calls for more home-manufactured pharma ...

In this article, we will be taking a look at the 15 unhealthiest countries in Latin America. You can also skip our detailed ...

Dupixent is indicated for the approximately 300,000 adults in the US with inadequately controlled COPD and an eosinophilic phenotypeFollowing recent approvals in the EU and China, the US approval is ...

U.S. stocks reacted positively following the Federal Open Market Committee's announcement in mid-September that it would lower interest rates by 50 basis points, wider than many analysts had ...

Dupixent has gained positive opinions from KOLs due to the positive data presented from the asset’s two Phase III clinical ...

The vaccine race: it was Brexit and Bingham what won it. There were good reasons for any member of the Tory Government to ...

Pfizer’s sudden market withdrawal of sickle cell therapy Oxbryta, which some analysts predicted would reach $750 million in ...

Britain's top brass filed into my office in No 10, bearing with them hundreds of years of collective operational experience, ...

The European Union Drugs Agency is dealing with new challenges to the rule of law as the illegal drugs trade surges. View on ...